Adjuvanted RSVPreF3 Vaccine Could Prevent RSV Infection Among Older Adults
The adjuvanted RSVPreF3 vaccine could prevent nearly 3 million symptomatic RSV-ARI cases among US older adults over 3 years’ time, according to study results.
The adjuvanted RSVPreF3 vaccine could prevent nearly 3 million symptomatic RSV-ARI cases among US older adults over 3 years’ time, according to study results.
AHRQ advances excellence in healthcare by producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable.
March 2024 R. Henry Olaisen, Ph.D., M.P.H., P.M.P., and Marc Roemer, M.S. Prior to the COVID-19 pandemic, 95 percent of all emergency department (ED) visits…
The grantees for AHRQ’s EvidenceNOW: Managing Unhealthy Alcohol Use Initiative are expected to work with more than 700 primary care practices to implement evidence-based approaches…
Blog highlights a landmark addition to AHRQ’s inventory of digital healthcare resources: Implementing the Digital Healthcare Equity Framework: A Practical Guide.
This webcast discussed Indiana Hospital Association’s experiences using the Surveys on Patient Safety Culture® (SOPS®) Hospital Survey and Workplace Safety Item Set. They shared their…
AHRQ advances excellence in healthcare by producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable.
Structural racism and discrimination can impede safe maternal care. This qualitative study among Black women highlighted how their severe maternal morbidity (SMM) experiences relate to manifestations…
The grantees for AHRQ’s EvidenceNOW: Managing Unhealthy Alcohol Use Initiative are expected to work with more than 700 primary care practices to implement evidence-based approaches…
Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.